IRIS
SALA, GIANLUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.004
EU - Europa 1.441
AS - Asia 1.070
SA - Sud America 165
AF - Africa 15
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.987
SG - Singapore 567
IT - Italia 437
IE - Irlanda 297
CN - Cina 258
SE - Svezia 185
BR - Brasile 150
DE - Germania 120
UA - Ucraina 88
TR - Turchia 72
FR - Francia 68
IN - India 56
GB - Regno Unito 54
FI - Finlandia 48
RU - Federazione Russa 44
VN - Vietnam 39
HK - Hong Kong 32
AT - Austria 23
BE - Belgio 19
NL - Olanda 13
CZ - Repubblica Ceca 11
CA - Canada 10
ZA - Sudafrica 9
BD - Bangladesh 7
GR - Grecia 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 5
IQ - Iraq 5
JP - Giappone 5
ES - Italia 4
PL - Polonia 4
IL - Israele 3
JM - Giamaica 3
LK - Sri Lanka 3
PY - Paraguay 3
RS - Serbia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AR - Argentina 2
AU - Australia 2
BB - Barbados 2
BG - Bulgaria 2
CL - Cile 2
EG - Egitto 2
LT - Lituania 2
MX - Messico 2
MY - Malesia 2
PE - Perù 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
QA - Qatar 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
Totale 4.699
Salva come PNG Salva come JPEG
Città #
Chandler 411
Singapore 376
Dublin 294
Jacksonville 178
Princeton 114
The Dalles 108
Ashburn 105
Ann Arbor 85
Santa Clara 79
Chieti 62
Beijing 61
Pescara 61
Altamura 52
Boardman 48
Munich 48
Nanjing 45
Dearborn 44
Izmir 36
Dong Ket 35
Los Angeles 35
Wilmington 34
Hong Kong 30
New York 28
Tongling 23
Southend 22
Brussels 19
Washington 18
Cambridge 16
Turku 16
Seattle 15
Lappeenranta 14
Nuremberg 14
Milan 13
Nanchang 13
Pune 13
Collecorvino 12
Hebei 11
Rome 11
Frankfurt am Main 10
Mcallen 10
Norwalk 10
Woodbridge 10
Vienna 9
Helsinki 8
Montesilvano 8
Shenyang 8
São Paulo 8
Brooklyn 7
Castignano 7
Falls Church 7
Zhengzhou 7
Brno 6
Fairfield 6
Houston 6
Johannesburg 6
Kunming 6
L’Aquila 6
Tianjin 6
Brasília 5
Dubai 5
Finale Ligure 5
London 5
Moscow 5
Olomouc 5
Phoenix 5
Rio de Janeiro 5
Salvador 5
Shijiazhuang 5
Stockholm 5
Belo Horizonte 4
Camerino 4
Campinas 4
Guarulhos 4
Jinan 4
Manchester 4
Newark 4
Redwood City 4
Romola 4
San Francisco 4
Tappahannock 4
Warsaw 4
Baghdad 3
Changsha 3
Chicago 3
Città Sant'Angelo 3
Colombo 3
Columbus 3
Dallas 3
Düsseldorf 3
Goiânia 3
Guangzhou 3
Hefei 3
Istanbul 3
Jiaxing 3
Lauterbourg 3
Napoli 3
Parma 3
Perugia 3
Presidente Prudente 3
Silvi 3
Totale 2.910
Salva come PNG Salva come JPEG
Nome #
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 144
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 134
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 133
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 118
ABCC3 is a novel target for the treatment of pancreatic cancer 114
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs) 113
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma 106
ERBB3 BINDING ANTIBODY 106
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 105
BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages 105
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 104
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 104
Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8(+) T cell number and tumour growth in pancreatic cancer 99
CAF-Derived IL6 and GM-CSF Cooperate to Induce M2-like TAMs–Letter 99
miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction. 98
Therapeutic efficacy of the novel stimuli-sensitive nano-ferritins containing doxorubicin in a head and neck cancer model 97
LGALS3BP antibody-drug-conjugate and its use for the treatment of cancer 95
Development of an anti-BAG3 humanized antibody for treatment of pancreatic cancer 93
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer 91
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 88
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer 86
Humanized anti-bag3 antibodies 85
The role of phospholipase Cγ1 in breast cancer and its clinical significance 80
Breast cancer in the era of integrating "Omics" approaches 80
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies 79
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine 79
The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1 78
EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo. 77
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 77
HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications 76
Phospholipase Cgamma1 is required for metastasis development and progression 76
BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration 73
An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling. 72
HER-3: Hub for escape mechanisms 71
The E27 β2-adrenergic receptor polymorphism reduces the risk of myocardial infarction in dyslipidemic young males 71
Antibody-drug conjugates: The new frontier of chemotherapy 71
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 68
Dual PDK1/aurora kinase a inhibitors reduce pancreatic cancer cell proliferation and colony formation 67
The role of phosphoinositide 3-kinase C2α in insulin signaling 63
Endosialin-binding antibody 63
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 61
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 60
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 60
Engineered human nanoferritin bearing the drug genz-644282 for cancer therapy 59
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines 58
Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools 57
Feedback inhibition by RALT controls signal output by the ErbB network 57
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 57
Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control 55
Concerted BAG3 and SIRPα blockade impairs pancreatic tumor growth 54
P63 role in breast cancer 53
High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors 53
Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin 51
Negative regulation of receptor tyrosine kinase signals 51
A phosphoinositide 3-kinase/phospholipase cgamma1 pathway regulates fibroblast growth factor-induced capillary tube formation 49
Role of BAG3 in cancer progression: A therapeutic opportunity 47
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET 44
Effects of an ErbB-3 antibody, MP-RM-1, on tumor growth and ligand-dependent and -independent activation of ErbB-3/akt signaling 44
MYC regulates metabolism through vesicular transfer of glycolytic kinases 44
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 40
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer 39
Cold atmospheric plasma activated media selectively affects human head and neck cancer cell lines 34
Therapeutic potential of antibody‐drug conjugate‐based therapy in head and neck cancer: A systematic review 31
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma 30
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target 30
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 29
Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers 28
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans 28
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth 27
Proteomic meta-analysis unveils new frontiers for biomarkers research in pancreatic carcinoma 20
null 20
Human head and neck cancer cell lines response to cold atmospheric plasma activated media is affected by the chemistry of culture media 18
A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy 18
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 5
Galectin-3-binding protein is a risk factor for Diabetes, Metabolic Syndrome, and Inflammation. Cross-sectional and Longitudinal Results from the InCHIANTI study 3
Totale 5.052
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.088
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021337 39 3 60 7 23 60 24 15 16 34 9 47
2021/2022333 15 2 5 62 18 12 13 23 29 20 28 106
2022/20231.065 94 175 71 124 92 176 49 89 129 12 38 16
2023/2024638 38 15 64 33 36 214 97 26 5 25 13 72
2024/20251.657 60 301 242 66 45 74 71 74 218 130 228 148
2025/2026131 131 0 0 0 0 0 0 0 0 0 0 0
Totale 5.052